导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 12.24% | 198/758 |
| 近一周 | -1.50% | 520/798 |
| 近一月 | -4.54% | 273/797 |
| 近一季 | -2.04% | 242/789 |
| 近半年 | 7.61% | 224/777 |
| 近一年 | 17.47% | 189/738 |
| 近两年 | 69.24% | 269/679 |
| 近三年 | 35.39% | 270/620 |
| 成立以来 | 186.00% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.34% 396/1070 |
14.93% 449/1101 |
- - |
- - |
| 2025 | 26.22% 559/1065 |
4.07% 473/1014 |
-1.57% 819/1038 |
21.48% 561/1050 |
1.43% 354/1065 |
| 2024 | 4.50% 442/1011 |
-5.77% 599/960 |
-0.88% 369/983 |
14.35% 268/991 |
-2.15% 462/1011 |
| 2023 | -19.34% 657/952 |
7.10% 219/880 |
-6.63% 619/895 |
-12.15% 688/915 |
-8.18% 768/952 |
| 2022 | -23.03% 439/867 |
-22.21% 648/773 |
12.77% 165/806 |
-14.20% 520/845 |
2.26% 312/867 |
| 2021 | 12.62% 210/740 |
13.48% 5/580 |
9.59% 369/659 |
-12.76% 572/704 |
3.82% 269/740 |
| 2020 | 49.59% 237/554 |
-10.70% 385/419 |
9.46% 402/466 |
22.98% 32/517 |
24.44% 73/554 |
| 2019 | 49.73% 151/410 |
25.13% 693/1149 |
-6.74% 829/1231 |
7.49% 152/390 |
19.36% 18/410 |
| 2018 | -23.64% 127/349 |
- - |
- - |
- - |
-13.00% 733/1080 |
| 2017 | 14.31% 116/285 |
- - |
- - |
- - |
- - |
| 2016 | -18.97% 112/205 |
- - |
- - |
- - |
- - |
| 2015 | 47.72% 27/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 大摩进取优选股票 VS. 东吴新产业精选股票A(580008) |